AI in Epidemiology Market to hit USD 3 Billion by 2030,

Selbyville, Delaware, Oct. 10, 2022 (GLOBE NEWSWIRE) —

The artificial intelligence in epidemiology market value is set to reach USD 3 billion by 2030, according to a new research report by Global Market Insights Inc.

Rising awareness about the role of technologies in chronic disease diagnosis and monitoring will be a prominent factor stimulating the advancement of AI use in epidemiology. Increasing healthcare research and development activities will thus drive the demand for the deployment of artificial intelligence in epidemiology labs.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/5364

AI in epidemiology market from the cloud-based segment is projected to record a lucrative CAGR in the coming years. The adoption of digital solutions across the healthcare sector, especially during the COVID-19 pandemic, has risen considerably. Cloud technology, especially, has become a potential game-changer for digital health. It can create a strong foundation for the growth of AI applications in epidemiology.

Infection prediction and forecasting segment accounted for more than 38% business share in 2021, given the rise in funding programs for healthcare research projects. In August 2022, the U.S. National Science Foundation invested over USD 7.5 million to facilitate new research. This research would be focused on the reliable prediction of infectious disease spread, the outcomes of mitigation measures, and other aspects of national health crises.

Browse key industry insights spread across 195 pages with 181 market data tables & 17 figures & charts from the report, “Artificial Intelligence in Epidemiology Market Analysis By Deployment (On-premise, Web-based, Cloud-based), Application (Infection Prediction & Forecasting, Disease & Syndromic Surveillance, Monitoring Population Health & Incidence/Prevalence), End-use (Government & State Agencies, Research Labs, Pharmaceutical & Biotechnology Companies,…